Ambea ABCHIX:AMBEAS 83 Days Payable is 274.75 as of Mar. 2026, which is 5% below its 10-year median of 289.53. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr120.97 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Ambea AB ranks better than 86.3% on this metric.
Ambea AB's average Accounts Payable for the
three
months ended in Mar. 2026 was kr413 Mil. Ambea AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr137 Mil.
Hence, Ambea AB's Days Payable for the
three
months ended in Mar. 2026 was 274.75.
The historical rank and industry rank for Ambea AB's Days Payable or its related term are showing as below:
CHIX:AMBEAs'
s Days Payable Range Over the Past 10 Years
Min: 221.1 Med: 289.53 Max: 388.8
Current: 231.53
During the past 12 years, Ambea AB's highest Days Payable was 388.80. The lowest was 221.10. And the median was 289.53.
CHIX:AMBEAs's Days Payable is ranked better than 86.3% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs CHIX:AMBEAs: 231.53
Ambea AB's Days Payable
increased
from Mar. 2025 (261.41) to Mar. 2026 (274.75).
It may suggest that Ambea ABdelayed paying its suppliers.
Ambea AB Days Payable Related Terms
Ambea AB Days Payable Historical Data
* Premium members only.
The historical data trend for Ambea AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Ambea AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Ambea AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ambea AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a Days Payable of 274.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ambea AB and its competitors. This is near median its historical median of 289.53. Over the past decade, Ambea AB's Days Payable has ranged from 221.10 to 388.80. According to the industry distribution chart, Ambea AB ranks #83 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 13.7%.
Is Ambea AB's Days Payable too high?
Ambea AB's current Days Payable of 274.75 is near median its 10-year median of 289.53. Over the past 10 years, this metric has ranged from a low of 221.10 to a high of 388.80. The Healthcare Providers & Services industry median Days Payable is 58.21. Ambea AB's value of 274.75 is 372% above this industry median. Based on the distribution chart, Ambea AB ranks #83 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #83 out of 606 companies for Days Payable. This places Ambea AB in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.21. Ambea AB's value of 274.75 is 372% above this benchmark. Historically, Ambea AB's own Days Payable has ranged from 221.10 to 388.80 over the past decade. While the company's 10-year median is 289.53 vs. the industry median of 58.21, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current Days Payable of 274.75 is 372% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current Days Payable is 274.75, which is near median its own 10-year median of 289.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr120.97, compared to a current price of kr140.40 — trading 16.1% above its estimated fair value. The current Days Payable is 274.75, which is near median its 10-year median of 289.53 and 372% above the Healthcare Providers & Services industry median of 58.21. Ambea AB's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Days Payable is 274.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr140.40 is trading 16.1% above its estimated GF Value™ of kr120.97.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
Days Payable: 274.75 (near median its 10-year median of 289.53)
GF Value™: kr120.97 vs. price of kr140.40 (16.1% above fair value)
Industry Position: 372% above the Healthcare Providers & Services median (#83 of 606)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score
Get the complete analysis for CHIX:AMBEAS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
